NTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Nutrien Ltd (NTR) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company shows strong financial growth, favorable long-term trends, and positive market sentiment, making it a compelling option for long-term investment despite minor short-term risks.
The stock is trading pre-market at $70.1 (-0.47%). Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. RSI is neutral at 51.444, and MACD is negative but expanding downward (-0.111). Key support and resistance levels are S1: 68.269, Pivot: 70.472, and R1: 72.674. Nutrien has recently reached 52-week highs, suggesting strong upward momentum.
Nutrien has reached new 52-week highs, indicating strong upward momentum.
The agribusiness sector is rebounding in 2026, with the MOO ETF up 17% YTD.
Analysts have raised price targets, with some projecting upside to $76 or higher.
Strong financial performance in Q3 2025, including a 12.32% YoY revenue increase and a 2477.78% YoY net income increase.
Hedge funds are selling, with a 116.85% increase in selling activity last quarter.
Analysts express caution about fertilizers due to potential oversupply and pricing pressures.
MACD is negative, indicating possible short-term weakness.
Stock trend analysis shows a 50% chance of short-term declines (-15.62% next day, -14.37% next week).
Nutrien's Q3 2025 financials show robust growth: Revenue increased by 12.32% YoY to $6.007 billion, Net Income surged 2477.78% YoY to $464 million, EPS rose 2300% YoY to 0.96, and Gross Margin improved by 16.58% YoY to 32.7%. These metrics highlight strong operational performance and profitability.
Analysts have mixed views. RBC and Oppenheimer maintain Outperform ratings with price targets of $75 and $76, respectively, citing strong fundamentals and potential catalysts. Scotiabank and Mizuho are more cautious, with Neutral ratings and lower price targets ($70 and $68). BofA remains Neutral, citing oversupply concerns but notes potential catalysts like rate cuts and capacity rationalization.
